These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20847451)

  • 21. Lesion-induced hippocampal plasticity in transgenic Alzheimer's disease mouse models: influences of age, genotype, and estrogen.
    Kadish I; van Groen T
    J Alzheimers Dis; 2009; 18(2):429-45. PubMed ID: 19584452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
    van Groen T; Miettinen P; Kadish I
    J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellar amyloid-β plaques: disturbed cortical circuitry in AβPP/PS1 transgenic mice as a model of familial Alzheimer's disease.
    Lomoio S; López-González I; Aso E; Carmona M; Torrejón-Escribano B; Scherini E; Ferrer I
    J Alzheimers Dis; 2012; 31(2):285-300. PubMed ID: 22561329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of hippocampal N-acetyl aspartate level in aged APP(Swe)/PS1(dE9) transgenic mice is associated with degeneration of CA3 pyramidal neurons.
    Xu W; Zhan Y; Huang W; Wang X; Zhang S; Lei H
    J Neurosci Res; 2010 Nov; 88(14):3155-60. PubMed ID: 20806406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
    Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
    Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.
    Wang Y; Tang XC; Zhang HY
    J Neurosci Res; 2012 Feb; 90(2):508-17. PubMed ID: 22002568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
    Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
    Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
    J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aβ-42 deposition significantly increases the insolubility of synaptophysin in the brains of hAPPsw/hPS2m double transgenic mice.
    Hwang DY; Jee SW; Lee SH; Bae CJ; Goo JS; Kim JE; Nam SH; Choi SI; Lee HR; Shim SB; Park MH; Hong JT; Kim HS
    Int J Mol Med; 2011 Aug; 28(2):223-9. PubMed ID: 21491079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
    Scullion GA; Kendall DA; Marsden CA; Sunter D; Pardon MC
    Neuropharmacology; 2011; 60(2-3):223-34. PubMed ID: 20850464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
    Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H
    J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.
    Ramalho RM; Nunes AF; Dias RB; Amaral JD; Lo AC; D'Hooge R; Sebastião AM; Rodrigues CM
    Neurobiol Aging; 2013 Feb; 34(2):551-61. PubMed ID: 22621777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.
    Lazarov O; Robinson J; Tang YP; Hairston IS; Korade-Mirnics Z; Lee VM; Hersh LB; Sapolsky RM; Mirnics K; Sisodia SS
    Cell; 2005 Mar; 120(5):701-13. PubMed ID: 15766532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9.
    Koronyo-Hamaoui M; Ko MK; Koronyo Y; Azoulay D; Seksenyan A; Kunis G; Pham M; Bakhsheshian J; Rogeri P; Black KL; Farkas DL; Schwartz M
    J Neurochem; 2009 Dec; 111(6):1409-24. PubMed ID: 19780903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
    Ding Y; Qiao A; Fan GH
    Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.